• Something wrong with this record ?

Parameter optimization in a continuous direct compression process of commercially batch-produced bisoprolol tablets

J. Lyytikäinen, P. Stasiak, T. Kubelka, T. Olenius, O. Korhonen, J. Ketolainen, T. Ervasti

. 2022 ; 628 (-) : 122355. [pub] 20221029

Language English Country Netherlands

Document type Journal Article

Continuous tablet manufacturing is a competitive option to replace the traditional batch manufacturing approach. The aim of this study was to evaluate technology transfer from batch-based direct compression of a commercial tablet formulation to continuous direct compression without changes to the composition of the formulation. Some powder studies were conducted with the raw materials and multi-tip punches were utilized in the tableting studies. To lower the high level of tablet weight variability that was evident during preliminary tests, a process parameter optimization was performed using an experimental design with different rpm values of force feeder and mixer impeller. By selecting the most appropriate settings of these parameters for the studied product, the weights of the tablets could be controlled adequately to meet the specification criteria. The functionality of the best-performing parameter settings was investigated with a three-hour-long tableting run. The tablets were evaluated with the same quality criteria as the commercial batch-produced tablets, and they passed all the tests performed in this study. Despite the challenging material properties according to the flowability tests, production of tablets with the desired quality was achieved using the original composition with continuous direct compression.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032589
003      
CZ-PrNML
005      
20230131151508.0
007      
ta
008      
230120s2022 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpharm.2022.122355 $2 doi
035    __
$a (PubMed)36341918
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Lyytikäinen, Jenna $u School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland. Electronic address: jenna.lyytikainen@uef.fi
245    10
$a Parameter optimization in a continuous direct compression process of commercially batch-produced bisoprolol tablets / $c J. Lyytikäinen, P. Stasiak, T. Kubelka, T. Olenius, O. Korhonen, J. Ketolainen, T. Ervasti
520    9_
$a Continuous tablet manufacturing is a competitive option to replace the traditional batch manufacturing approach. The aim of this study was to evaluate technology transfer from batch-based direct compression of a commercial tablet formulation to continuous direct compression without changes to the composition of the formulation. Some powder studies were conducted with the raw materials and multi-tip punches were utilized in the tableting studies. To lower the high level of tablet weight variability that was evident during preliminary tests, a process parameter optimization was performed using an experimental design with different rpm values of force feeder and mixer impeller. By selecting the most appropriate settings of these parameters for the studied product, the weights of the tablets could be controlled adequately to meet the specification criteria. The functionality of the best-performing parameter settings was investigated with a three-hour-long tableting run. The tablets were evaluated with the same quality criteria as the commercial batch-produced tablets, and they passed all the tests performed in this study. Despite the challenging material properties according to the flowability tests, production of tablets with the desired quality was achieved using the original composition with continuous direct compression.
650    12
$a bisoprolol $7 D017298
650    _2
$a tablety $7 D013607
650    _2
$a prášky, zásypy, pudry $7 D011208
650    _2
$a tlak $7 D011312
650    12
$a farmaceutická technologie $7 D013678
650    _2
$a příprava léků $7 D004339
655    _2
$a časopisecké články $7 D016428
700    1_
$a Stasiak, Pawel $u Zentiva, Prague, Czech Republic. Electronic address: pawel.stasiak@zentiva.com
700    1_
$a Kubelka, Tomáš $u Zentiva, Prague, Czech Republic. Electronic address: Tomas.Kubelka@zentiva.com
700    1_
$a Olenius, Tino $u School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland. Electronic address: tino.olenius@uef.fi
700    1_
$a Korhonen, Ossi $u School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland. Electronic address: ossi.korhonen@uef.fi
700    1_
$a Ketolainen, Jarkko $u School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland. Electronic address: jarkko.ketolainen@uef.fi
700    1_
$a Ervasti, Tuomas $u School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland. Electronic address: tuomas.ervasti@uef.fi
773    0_
$w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 628, č. - (2022), s. 122355
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36341918 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151504 $b ABA008
999    __
$a ok $b bmc $g 1891387 $s 1183924
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 628 $c - $d 122355 $e 20221029 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
LZP    __
$a Pubmed-20230120

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...